Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Current Deferred Tax Assets (2017)

Assembly Biosciences has reported Current Deferred Tax Assets over the past 1 years, most recently at $4.9 million for Q4 2017.

  • Quarterly results put Current Deferred Tax Assets at $4.9 million for Q4 2017, changed N/A from a year ago — trailing twelve months through Dec 2017 was $4.9 million (changed N/A YoY), and the annual figure for FY2017 was $4.9 million, changed.
  • Current Deferred Tax Assets for Q4 2017 was $4.9 million at Assembly Biosciences.
  • Over the last five years, Current Deferred Tax Assets for ASMB hit a ceiling of $4.9 million in Q4 2017 and a floor of $4.9 million in Q4 2017.